LamdaGen markets label-free detection systems for bioresearch and bioprocess applications based on the use of our patented LSPR (localized surface plasmon resonance) technology which we also out-license for integration into a variety of OEM applications. LSPR is used to characterize diverse biomolecular interactions between targets such as DNA, RNA, proteins, peptides and low molecular weight compounds. We also provide patent-pending amplification technology to assist our clients in staying on the cutting edge of diagnostic screening and quantitation. LamdaGen???s LSPR nano-based optical sensor platform enables a simple, yet significant business model which can generate multiple revenue streams with compelling profit margins.